Han H, Yang L, L R, L F, Wu KL, LJ, L XH, Zhu CL. Proment changes blood coagulatn of patnts wh SARS-CoV-2 fectn. Cl Chem Lab Med. 2020 Jun 25;58(7):1116-1120. do 10.1515/cclm-2020-0188. Tang N, LD, Wang X, Sun Z. Abnormal coagulatn parameters are assocted wh poor prognos patnts wh novel coronavus pneumon. J Thromb Haemost. 2020 Apr;18(4):844-847. do 10.1111/jth.14768. Epub 2020 Mar 13. Zhou F, Yu T, Du R, Fan G, L Y, L Z, Xng J, Wang Y, Song B, Gu X, Guan L, WeY, LH, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clal course and rk factors for mortaly of adult patnts wh COV-19 Wuhan, Cha: a retrospecte cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. do 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum : Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038. Wu C, Chen X, CaY, X J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xng W, Xu L, Zhou F, Jng J, BaC, Zheng J, Song Y. Rk Factors Assocted Wh Acute Respatory Dtress Syndrome and Death Patnts Wh Coronavus Dease 2019 Pneumon Wuhan, Cha. JAMA tern Med. 2020 Jul 1;180(7):934-943. do 10.1001/jamaternmed.2020.0994. Erratum : JAMA tern Med. 2020 Jul 1;180(7):1031. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Q Y, Wang J, L Y, WeY, X J, Yu T, Zhang X, Zhang L. Epemlogal and clal characterts of 99 cases of 2019 novel coronavus pneumon Wuhan, Cha: a descrte study. Lancet. 2020 Feb 15;395(10223):507-513. do 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30. McGonagle D, Shar K, O'Regan A, Brgewood C. The Role of Cytokes cludg terleuk-6 COV-19 duced Pneumon and Macrophage Actatn Syndrome-Le Dease. Automun Rev. 2020 Jun;19(6):102537. do 10.1016/j.autrev.2020.102537. Epub 2020 Apr 3. Tang N, BaH, Chen X, Gong J, LD, Sun Z. Antoagulant treatment assocted wh decreased mortaly severe coronavus dease 2019 patnts wh coagulopathy. J Thromb Haemost. 2020 May;18(5):1094-1099. do 10.1111/jth.14817. Epub 2020 Apr 27. a T, N MD, Levy JH, Kamura N, Thach J. New crer for seps-duced coagulopathy (S) followg the reved seps defn: a retrospecte analys of a natnwe survey. BMJ Open. 2017 Sep 27;7(9):e017046. do 10.1136/bmjopen-2017-017046. Young E. The antflammatory effects of hepar and related compounds. Thromb Res. 2008;122(6):743-52. do 10.1016/j.thromres.2006.10.026. Epub 2007 Aug 28. Poterucha TJ, Lby P, Goldhaber SZ. More than an antoagulant: Do hepars have dect antflammatory effects? Thromb Haemost. 2017 Feb 28;117(3):437-444. do 10.1160/TH16-08-0620. Epub 2016 Dec 15. MousavS, MoradM, Khorshahmad T, MotamedM. Antflammatory Effects of Hepar and s Derates: A Systemat Revw. Adv Pharmacol Sc 2015;2015:507151. do 10.1155/2015/507151. Epub 2015 May 12. Thach J. The versate hepar COV-19. J Thromb Haemost. 2020 May;18(5):1020-1022. do 10.1111/jth.14821. Epub 2020 Apr 27. No abstract avaable. Mewska A, ZarebskM, Nowak P, Stozek K, Potempa J, Pyrc K. Human coronavus NL63 utes heparan sulfate proteoglycans for attachment to target cells. J Vol. 2014 Nov;88(22):13221-30. do 10.1128/JV02078-14. Epub 2014 Sep 3. Barrett CD, Moore HB, Yaffe MB, Moore EE. TH ter guance on recognn and management of coagulopathy COV-19: A comment. J Thromb Haemost. 2020 Aug;18(8):2060-2063. do 10.1111/jth.14860. Epub 2020 Jun 14. No abstract avaable. Wada H, Thach J, DN M, Mathew P, Kurosawa S, Gando S, K HK, Nlsen JD, Dempfle CE, LevM, Toh CH; The Scnt Standardatn Commtee on D of the ternatnal Socty on Thrombos Haemostas. Guance for dgnos and treatment of D from harmonatn of the recommendatns from three gueles. J Thromb Haemost. 2013 Feb 4. do 10.1111/jth.12155. Onle ahead of prt. Schulman S, Kearon C; Subcommtee on Control of Antoagulatn of the Scnt and Standardatn Commtee of the ternatnal Socty on Thrombos and Haemostas. Defn of major bleedg clal vestatns of antemostat medal products non-surgal patnts. J Thromb Haemost. 2005 Apr;3(4):692-4. do 10.1111/j.1538-7836.2005.01204.x. Ackermann M, Verleden SE, Kuehnel M, Haverh A, Welte T, Laenger F, Vanstapel A, Werle C, Stark H, Tzankov A, LWW, LVW, Mentzer SJ, Jonk D. Pulmonary Vascular Endothell, Thrombos, and Anggenes Cov-19. N Engl J Med. 2020 Jul 9;383(2):120-128. do 10.1056/NEJMoa2015432. Epub 2020 May 21. Helms J, Tacquard C, Severac F, Leonard-Lorant Ohana M, Delabranche X, MerdjH, Clere-Jehl R, Schenck M, Fagot Gandet F, FafKremer S, Castela V, Schneer F, Grunebaum L, Angles-Cano E, Sattler L, Mertes PM, MeznF; CRS TRGERSEP Group (Clal Research tense Care and Seps Trl Group for Global Evaluatn and Research Seps). Hh rk of thrombos patnts wh severe SARS-CoV-2 fectn: a multenter prospecte cohort study. tense Care Med. 2020 Jun;46(6):1089-1098. do 10.1007/s00134-020-06062-x. Epub 2020 May 4. Enoxaparin at Prophylactic or Therapeutic Doses With Monitoring of Outcomes in Subjects Infected With COVID-19: a Pilot Study on 300 Cases Enrolled at ASST-FBF-Sacco
Journal of cultural heritage 14 (2013): E153–E160. doi:10.1016/j.culher.2012.10.020 info:cnr-pdr/source/autori:Rebollo, Elena; Nodari, Luca; Russo, Umberto; Bertoncello, Renzo; Scardellato, Chiara; Romano, Florindo; Ratti, Filippo; Poletto, Luca/titolo:Non-invasive multitechnique methodology applied to the study of two 14th century canvases by Lorenzo Veneziano/doi:10.1016%2Fj.culher.2012.10.020/rivista:Journal of cultural heritage/anno:2013/pagina_da:E153/pagina_a:E160/intervallo_pagine:E153–E160/volume:14